Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma
- 1 October 1986
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 7 (3) , 129-145
- https://doi.org/10.1007/bf01806244
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.BMJ, 1985
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerBreast Cancer Research and Treatment, 1984
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- GnRH superagonist analog treatment of prostate cancer: Hormonal effects with and without an androgen biosynthesis inhibitorJournal of Steroid Biochemistry, 1984
- Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal womenJournal of Steroid Biochemistry, 1984
- Treatment of prostatic cancer with LH-RH analoguesThe Prostate, 1983
- Short-Term Treatment of Idiopathic Precocious Puberty with a Long-Acting Analogue of Luteinizing Hormone-Releasing HormoneNew England Journal of Medicine, 1981